| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alcohol consumption and renal cell cancer risk in two Italian case–control studies
|
Pelucchi, C.
|
|
|
19 |
5 |
p. 1003-1008
|
artikel
|
| 2 |
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
|
Schmid, P.
|
|
|
19 |
5 |
p. 871-876
|
artikel
|
| 3 |
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
|
Glimelius, B.
|
|
|
19 |
5 |
p. 909-914
|
artikel
|
| 4 |
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
|
Cullen, M.H.
|
|
|
19 |
5 |
p. 939-945
|
artikel
|
| 5 |
A randomized phase II study of ixabepilone (BMS-247550) given daily × 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study
|
Burtness, B.A.
|
|
|
19 |
5 |
p. 977-983
|
artikel
|
| 6 |
Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management
|
Penack, O.
|
|
|
19 |
5 |
p. 984-989
|
artikel
|
| 7 |
Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
|
Mourad, J.-J.
|
|
|
19 |
5 |
p. 927-934
|
artikel
|
| 8 |
Burden of cervical cancer in Europe: estimates for 2004
|
|
|
|
19 |
5 |
p. 1030
|
artikel
|
| 9 |
Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations
|
Héry, C.
|
|
|
19 |
5 |
p. 1009-1018
|
artikel
|
| 10 |
Cigarette smoking and site-specific cancer mortality: testing uncertain associations using extended follow-up of the original Whitehall study
|
Batty, G.D.
|
|
|
19 |
5 |
p. 996-1002
|
artikel
|
| 11 |
Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables
|
Sastre, J.
|
|
|
19 |
5 |
p. 935-938
|
artikel
|
| 12 |
Developing innovative models for North–South cooperation in clinical research—experience from the INDOX Cancer Research Network
|
Ali, R.
|
|
|
19 |
5 |
p. 831-833
|
artikel
|
| 13 |
Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial
|
Barrett, S.V.
|
|
|
19 |
5 |
p. 898-902
|
artikel
|
| 14 |
ErbB/HER receptor family in breast cancer—the more we search the more we learn
|
Karamouzis, M.V.
|
|
|
19 |
5 |
p. 1020-1021
|
artikel
|
| 15 |
Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival
|
Ludovini, V.
|
|
|
19 |
5 |
p. 883-890
|
artikel
|
| 16 |
Factors influencing the decision to take or reject opioids for cancer pain: are we on target?
|
Apolone, G.
|
|
|
19 |
5 |
p. 1021-1022
|
artikel
|
| 17 |
Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology
|
Ganeshan, A.
|
|
|
19 |
5 |
p. 847-851
|
artikel
|
| 18 |
Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine
|
Jaeger, G.
|
|
|
19 |
5 |
p. 1025-1026
|
artikel
|
| 19 |
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
|
Mercadal, S.
|
|
|
19 |
5 |
p. 958-963
|
artikel
|
| 20 |
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
|
Ingle, J.N.
|
|
|
19 |
5 |
p. 877-882
|
artikel
|
| 21 |
In this issue
|
|
|
|
19 |
5 |
p. 827
|
artikel
|
| 22 |
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
|
Köhne, C.-H.
|
|
|
19 |
5 |
p. 920-926
|
artikel
|
| 23 |
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study
|
Re, A.
|
|
|
19 |
5 |
p. 951-957
|
artikel
|
| 24 |
MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
|
Chen, J.H.
|
|
|
19 |
5 |
p. 1024-1025
|
artikel
|
| 25 |
Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy
|
Ferreri, A.J.M.
|
|
|
19 |
5 |
p. 835-846
|
artikel
|
| 26 |
Optimisation of circulating biomarkers of cell death for routine clinical use
|
Greystoke, A.
|
|
|
19 |
5 |
p. 990-995
|
artikel
|
| 27 |
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
|
Rosenberg, J.E.
|
|
|
19 |
5 |
p. 946-950
|
artikel
|
| 28 |
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma
|
Crump, M.
|
|
|
19 |
5 |
p. 964-969
|
artikel
|
| 29 |
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00
|
Fountzilas, G.
|
|
|
19 |
5 |
p. 853-860
|
artikel
|
| 30 |
Predicting response of molecular targeted therapies: a still possible challenge?
|
Labianca, R.
|
|
|
19 |
5 |
p. 829-830
|
artikel
|
| 31 |
Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours
|
Bettini, R.
|
|
|
19 |
5 |
p. 903-908
|
artikel
|
| 32 |
Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes
|
Wimazal, F.
|
|
|
19 |
5 |
p. 970-976
|
artikel
|
| 33 |
Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
|
Soong, R.
|
|
|
19 |
5 |
p. 915-919
|
artikel
|
| 34 |
Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim
|
Ishiguro, H.
|
|
|
19 |
5 |
p. 1019
|
artikel
|
| 35 |
Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy
|
Baek, H.-M.
|
|
|
19 |
5 |
p. 1022-1024
|
artikel
|
| 36 |
Reply to Letter to the editor, by Ishiguro et al. (Ann Oncol)
|
Piedbois, P.
|
|
|
19 |
5 |
p. 1019-1020
|
artikel
|
| 37 |
Table of Contents
|
|
|
|
19 |
5 |
p. ii-iv
|
artikel
|
| 38 |
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial
|
Gluz, O.
|
|
|
19 |
5 |
p. 861-870
|
artikel
|
| 39 |
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
|
Nolé, F.
|
|
|
19 |
5 |
p. 891-897
|
artikel
|
| 40 |
Volume 18, Supplement 2, ESMO Clinical Recommendations
|
|
|
|
19 |
5 |
p. 1027-1029
|
artikel
|
Tijdschrift beschrijving